$SMTI Cashflow Statement | Understand Stock

$SMTI

$32.88 +$0.04 (0.12%) Close

$SMTI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss on disposal of property and equipment
Depreciation and amortization
Asset impairment charges
Gain on disposal of property and equipment
Credit loss expense
Inventory obsolescence
Share-based compensation
Accretion of earnout liabilities
Noncash lease expense
Share of losses from equity method investments
Gain on disposal of investment
Benefit from deferred income taxes
Back-end fee
Paid-in-kind interest
Accretion of finance liabilities
Amortization and write-off of debt issuance costs
Change in fair value of earnout liabilities
Accrued interest income
Changes in operating assets and liabilities:
Accounts receivable, net
Accounts receivable – related parties
Inventory, net
Prepaid and other assets
Accounts payable
Accounts payable - related parties
Accrued bonus and commissions
Accounts payable – related parties
Accrued royalties and expenses
Accrued bonuses and commissions
Operating lease liabilities

Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from disposal of property and equipment
Purchases of intangible assets
Investment in equity securities
Convertible loan receivable
Acquisitions, net of cash acquired
CarePICS Acquisition
Net cash used in investing activities
Cash flows from financing activities:
Draw on line of credit
Loan proceeds, net of debt issuance costs of $228,183 in 2025 and $1,160,740 in 2024
Pay off line of credit
Pay off debt assumed in CarePICS Acquisition
Equity offering net expenses
Net settlement of equity-based awards
Distribution to noncontrolling interest member
Cash payment of finance and earnout liabilities
Net cash provided by financing activities

Net increase in cash
Cash, beginning of period
Cash, end of period
Cash paid during the period for:
Interest
Taxes
Supplemental noncash investing and financing activities:
Non-monetary exchange to acquire intangible assets
Conversion of note receivable into equity method investment
Earnout liability generated by CarePICS Acquisition
Investment in equity securities converted in asset acquisition
License agreement as capital contribution from noncontrolling interest member
Right of use assets obtained in exchange for lease obligations
Equity issued for acquisitions

Comments